Trial shows Oxford-developed COVID-19 vaccine offers only "minimal" protection against mild to moderate illness from South Africa variant.
from Home - CBSNews.com https://ift.tt/3q1MmNB
from Home - CBSNews.com https://ift.tt/3q1MmNB
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment